SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001815776-24-000042
Filing Date
2024-05-08
Accepted
2024-05-08 17:11:18
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lenz-20240331.htm   iXBRL 10-Q 1253176
2 EX-31.1 exhibit311.htm EX-31.1 10739
3 EX-31.2 exhibit312.htm EX-31.2 10741
4 EX-32.1 exhibit321.htm EX-32.1 5351
5 EX-32.2 exhibit322.htm EX-32.2 5353
  Complete submission text file 0001815776-24-000042.txt   5448529

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lenz-20240331.xsd EX-101.SCH 36885
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lenz-20240331_cal.xml EX-101.CAL 44664
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lenz-20240331_def.xml EX-101.DEF 200326
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lenz-20240331_lab.xml EX-101.LAB 489554
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lenz-20240331_pre.xml EX-101.PRE 336396
64 EXTRACTED XBRL INSTANCE DOCUMENT lenz-20240331_htm.xml XML 531848
Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 24927449
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)